Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial

已完结 10 由 sz 发布于 2025/10/12 9:11:30

DOI:10.1038/s41591-024-03003-9
作者：Xiaohua Wu, Jihong Liu, Jing Wang, Li Wang, Zhongqiu Lin, Xiaobin Wang, Jianqing Zhu, Beihua Kong, Junwei Fei, Ying Tang, Bairong Xia, Zhiqing Li
文献类型：期刊论文
补充材料：只需要正文

Nature

Abstract：Poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors as maintenance therapy after first-line chemotherapy have improved progression-free survival in women with advanced ovarian ca

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:NatureSenaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial